Skip to Content

Check Out My MoneyLine Podcast!

There is so much to talk about when it comes to mega-trends that are changing our world and the potential for investors to get rich that I’ve started a weekly podcast!

It will soon be available on all of the major podcast platforms, but you can click here to listen to it now.

Trend Highlights

The Latest News Shows This is Just the Start of Massive Potential in This Overlooked Industry

Nov 16, 2019

By now, I hope you have a sense for how incredible the opportunity is in Chinese biotech stocks. We’ve been talking about it here in MoneyWire for the last two weeks. The government is pushing the sector – targeting 116X growth. The people need better treatments, especially for cancer. And the country’s new and improved version of the FDA opens the door for drugs developed by Chinese biotech companies to quickly expand internationally. This is an investment theme that will grow over many years. But on Thursday night, we got fresh evidence that the train is starting to leave the station. Continue Reading…

MoneyLine: The Three Stocks You Need on Your Watchlist Today

Nov 15, 2019

What a week! The impeachment hearings are making headlines, an NFL player is suspended for using a helmet as a weapon, and Disney+ launched. While all three are worth looking into a little more, the big stories in the market continue to be relegated to the depths of the internet. So, in this week’s MoneyLine podcast, I dive into what investors need to know. The show kicks off with what you asked for: a look at the current state of cannabis stocks. I did a poll on Twitter, and that was overwhelmingly the topic people voted for. Your timing was good, as a flood of earnings was released this week. Continue Reading…

The 100X Play As Big Pharma Money Moves Into China

Nov 14, 2019

Last week, I told you a bit about a major story that got nowhere near the attention it deserved. It’s further evidence of the massive opportunity we’ve talked about the last few days. U.S. biotech giant Amgen (AMGN) announced plans to invest $2.7 billion for a 20% stake in the Chinese biotech firm BeiGene (BGNE). Amgen’s move sent BeiGene’s stock soaring over 30% the day the news broke. Even the acquirer, Amgen, has been able to gain roughly 10% this month. But too many people looked past the news… or they don’t know its significance and how it points to the massive opportunity in Chinese biotech stocks. Continue Reading…

Latest Research Report

How to Avoid The 2019 Marijuana Stock Apocalypse

Latest Update: 2019

My personal history in the marijuana market might make what I have to say about marijuana stocks utterly shocking to most people: I believe a huge swath of marijuana investors — potentially millions of people — are about to get wiped out in weed stocks. Some of my longtime readers will think I’ve lost my mind. But after I lay out my analysis, I’m confident you’ll agree with me: Many weed investors are about to suffer huge losses. In this report, I’ll walk you through my thinking… urge you to avoid the most toxic popular marijuana stocks… and steer you towards the absolute best weed stocks that will survive and thrive during the coming “Marijuana Stock Apocalypse.” Continue Reading…

Question of the Day

I’ve noticed that many of the stocks you follow are either small or mid-caps. Why is that?

In my NexGen newsletters, our strategy is to look for stocks that have big upside potential in powerful mega-trends that are changing our world. That often leads to smaller, lesser known companies, so by default the majority of the stocks we follow are either small- or mid-cap companies. Many people believe these stocks inherently have more risk, but not only is that a very broad generalization, it is also completely untrue. At one point in time, all large companies were small caps that flourished and grew into today’s leaders. Our goal is to find tomorrow’s leaders now in their early stages and own the stock before Wall Street has caught on to the big picture. We can make a lot of money that way.

Continue Reading…

Submit A Question

Questions for Matt?

Send along your question and Matt will get back to you as quickly as possible.

Track Record

SymbolCompany NameSell DateProfit
KERNAkerna (1/4 position)6/20/2019546.1%
KERNAkerna (1/4 position)6/19/2019153.5%
IIPRInnovative Industrial Prop. (1/3 position)6/13/2019201%
FMCFMC Corp.2/22/20192.6%
CCSCentury Communities6/14/20189.3%
BRBroadridge Financial Solutions 6/13/201837.6%
EEMiShares MSCI Emerging Markets ETF6/5/20184%
XBISPDR S&P Biotech ETF6/5/201811.9%
ANGIANGI Homeservices6/1/20188.3%
COPXGlobal X Miners ETF5/14/20189.6%
EUFNiShares MSCI Europe Financials5/14/20184.2%
SQMChemical & Mining Company of Chile5/14/201811.8%
GPNGlobal Payments2/16/201820.1%
View Track Record


What Investors Have to Say About Matt

  • Your technical analysis and charting are spot on!

    — Jane S.

  • Over the years I have bought many services. Most are overpriced and disappoint. Yours is excellent! I like your approach, and I like the lesser priced stocks primed for growth. They would be hard to find on my own. As long as you continue to do that kind of job, I'm sticking around!

    — Jon T.

  • From a "boomer" trying to hasten retirement ... I just wanted to thank you for the informative coherent communication during the "Brexit" fiasco. It's comforting to know that someone is at the wheel, so to speak. I hung in there, bought more bargains and profited significantly as a result. Thanks for your vigilant communications

    — Randy M.

  • Thank you for helping me build my portfolio!

    — James H.

  • I love Matt's video!!! Keep them coming.

    — Suzanne L.

  • Matt's videos explaining the charts are both informative and educational. Keep up the great work!

    — Steve L.

  • I'm pleased with your suggested stock purchases and how you skillfully use the charts to determine the future direction of a stock!

    — Anonymous

  • I really appreciated the trade advice. I was puzzled about how to cover Election Day. These trades will help and make me feel more confident.

    — Anonymous

Don't miss out on the incredible megatrends that are shaping today's market. Gain access to the most powerful market insights and stock advice from Matt McCall absolutely FREE. Join Today!